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Abstract
To what extent can one’s mind promote direct changes to the body? Can one’s beliefs about the body become a
physical reality, without mediating effects from behaviors? Specifically, can medical symptoms and the course of a
disease be directly affected by a person’s mindset about the illness?
There is a vast literature about placebo and nocebo effects, that promote physical changes by creating the
expectation of a change through a primer (for example, a fake pill). Placebos, however, often imply deception, or at
least ambiguity, to be effective. The concept of Illness Expectation describes the expectations, both implicit and
explicit, that a person who has received a diagnosis makes about the course of the disease. It can be characterized
by different degrees of rigidity, and it is argued here that these expectations can ultimately lead to changes in the
disease progression. These changes may happen through behavior modifications, or through a non-behavioral
pathway, which may deserve exploration efforts from the scientific literature.
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Mind, body, and placebo
The relationship between mind and body has a long his-
tory in both medicine and psychology. Beginning with
Descartes, the mind/body concepts were based on a
strict dualism. More recent investigations, however,
demonstrate a strong interaction between mind and
body, effectively collapsing the dualistic construct [1].
Among the most studied effect that the mind exerts on
the body is the placebo/nocebo effect, in which physio-
logical changes emerge following the assumption of inert
or non-specific treatment components [2]. As there is
no active therapeutic component in placebos, their ef-
fects are generally attributed to the patient’s beliefs of ef-
ficacy of the treatment. Placebo effects, or placebo
response, refer to the desirable effects, either subjective
(psychological) or objective (physiological), while nocebo
effects refer to the anticipated negative effects promoted
by a treatment (e.g., side effects). Given their clinical
relevance, there has been a growing interest in studying
the placebo and nocebo mechanisms, though there are
still several open questions [3]. For example, deception
(e.g., not informing the patient that the pill is inert) or,
more commonly, ambiguity (e.g., patients are told that it
is uncertain what treatment they are receiving) can be a
source of ethical challenges. Of course, the placebo re-
sponse is not always obtained through a lack of, or lim-
ited information (see, for example, the emerging open-
label placebo model [4, 5]). Moreover, both placebo and
nocebo responses are not restricted to inert or “fake” in-
terventions, but they can modulate the effects of drugs
and other therapies [6]. The placebo effect depends on
several aspects [7], including psychological processes
(e.g., implicit learning and previous experiences), social
and contextual factors (e.g., the patient-provider rela-
tionship, treatment characteristics), and biological mech-
anisms (body’s healing properties and neurophysiological
processes). The beliefs about the intervention are also
influenced by psychological traits, such as optimism [8]
and spirituality [9], even though situational variables
seem to play a bigger role for the placebo effects than in-
dividual characteristics [10].
Effects of expectations on the body
One of the main operational mechanisms of placebos is
represented by cognitive expectations, which in turn are
expected to promote the occurrence of physiological
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changes in the body [11]. In general, placebo and nocebo
effects have been studied with a primer, such as a sugar
pill, that influences or conditions the person to antici-
pate an effect. The expectation of a medical effect pro-
motes both subjective and objective (physiologic)
changes, with clinical improvements or worsening [12].
However, expectations are not only prompted by drugs
or interventions. In fact, every individual with a medical
condition develops a certain mindset toward the illness
[13], with expectations that spontaneously emerge.
These expectations, which represent the result of the
elaboration process of the information collected about
the disease [14], can promote different physiological ef-
fects [15]. For example, blood glucose levels in people
with type II diabetes are influence by perceived time and
expected values, rather than being a mere physiological
process [16]. Furthermore, expectations can influence
the ageing process: older adults who think about ageing
as associated with negative characteristics tend to ex-
perience a greater loss of physical function and a re-
duced survival, compared to those who held positive
expectations [17].
Illness perceptions and health beliefs
Expectations about the disease are a central component
of illness perceptions and health beliefs, which are well-
established concepts in health psychology [18]. Illness
Perception is often explored within the theoretical
framework of the Common Sense Model (CSM) of Ill-
ness Representation [19]. In the CSM theory, patient’s
illness perceptions include beliefs about what precipi-
tated the illness (causes), how long it will last (timeline),
the impact on the patient’s life (consequences), which
symptoms are attributed to the illness (identity), and
how the condition can be controlled or cured by the pa-
tient’s behavior (personal control) or by the treatment
(treatment control). In the CSM, expectations are con-
sidered as an underlying component of the different be-
liefs [20, 21]. Emotional components are another key
aspect of the CSM, which may interfere with cognitive
processing, and it could be a source of confusion during
the assessment process. For example, one of the most
utilized instruments for the assessment of illness percep-
tion, the Brief Illness Perception Questionnaire [22] in-
cludes items like “How much does your illness affect
you emotionally?”, which are somehow related to the ex-
pectations, but refer directly to the emotional domain.
The same concern deals with questions about conse-
quences in everyday life (e.g., “My illness has serious
economic and financial consequences”, from the Illness
Perception Questionnaire Revised [23]).
Thus far, most published research referencing the Ill-
ness Perception construct focuses on the role of disease
representations in explaining both coping and outcomes
in patients with a wide range of health conditions [24,
25]. Specifically, health psychologists have explored how
disease representations can lead to lifestyle modifica-
tions, eventually leading to changes in the medical out-
comes [26]. For example, adherence to the medical
treatment, or lifestyle choices like eating, exercising, or
smoking, can be influenced by illness representations. A
person who perceives that nothing can change the
course of the disease, for example, may be more prone
to avoid exercising or taking prescribed medicine [27].
In other words, the effects of Illness Perceptions on the
body (namely, on the course of the disease or its symp-
toms) have been mainly explored as mediated by behav-
ior changes [28]. The main difference between the
construct of Illness Perception and Illness Expectation is
their specificity: while the former is a multifaceted con-
cept that includes several aspects of the illness experi-
ence, the latter is a specific element, the anticipation of
the future illness-related scenarios, which is merely
cognitive.
Emotions and somatic changes
While the influence of psychological factors on the body
has been explored with the mediating effect of behavior
changes, there is also a vast literature that has investi-
gated the relationship between negative affects, such as
stress and depression, and medical outcome. Fields such
as psychoneuroendocrinology and psychoneuroimmun-
ology have been explicitly created to investigate these re-
lationships. Briefly, we know that negative emotions
(e.g., depression, stress) have, among other effects, a
strong impact on human physiology [29], often reflecting
on poorer medical outcomes, in the case of chronic dis-
eases. For example, depressive states and stress have
been associated with reduced survival rate in patients
with cancer [30]. The mechanisms underlying these as-
sociations are still under investigation.
Illness expectations
Despite the vast placebo/nocebo literature, expectations
are not typically manipulated directly and are often dis-
cussed in unison with an inert agent. Expectations seem
to have a role in illness beyond the delivery of (fake)
treatments. This situation leaves some ambiguity when
the findings on placebo effects apply and when they do
not. For this reason, it could be relevant to isolate a spe-
cific model, that specifically refers to the expectations
that a person has toward his/her illness. I suggest to de-
fine this construct “Illness Expectation” (IE). IE is the
cognitive schema that defines the expected characteris-
tics of the disease progression and future-oriented beliefs
about the symptoms. Like other expectations [20], IEs
can manifest as explicit (conscious) future-directed cog-
nitions, or they may be implicit, without an individual’s
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full awareness. There could be a certain level of overlap
between conscious and unconscious processes [31], but
though they do not necessarily converge. For example, a
person can be well-informed about the expected trajec-
tory of his/her disease, but it is also possible that, impli-
citly, (s)he represents future developments of the
symptoms in a different way. The expectations are based
on the supposed knowledge about the diagnosis and the
illness [32]. They are therefore influenced by the infor-
mation received, as well as by the cognitive and emo-
tional elaboration processes, which rely on personal
history and skills. Verbal information, patient-clinician
interactions, and prior experiences or previous condi-
tioning, as well as personality and other psychological
factors (e.g., optimism) may influence the expectation
creation, similar to how they influence the placebo re-
sponse [33, 34]. Illness Expectations could be seen as a
specific form of response expectancy, defined by Kirsch
[35] as the anticipation of non-volitional responses.
As with other psychological constructs, IEs reflect in-
dividual differences, that is, people with the same diag-
nosis and who have received similar information may
have different expectations. The same psychological
traits that influence the development of the treatment
expectations, which may module the placebo response,
may be involved in the characterization of Illness Expec-
tations. For example, it is possible that optimism and
spirituality have a positive impact, which would be in
line with the positive associations found with these two
variables and health [36]. At the same time, social and
contextual aspects, such as the patient-physician rela-
tionship and trust, social support, could play a role in
modulating the expectations. Future studies are required
to understand the possible role of these variables.
A crucial factor that mediates the effects of IE is cog-
nitive rigidity. As a cognitive schema, expectations may
additionally incorporate different degrees of rigidity, ran-
ging from a mild expectation to a very strict conception
of what “will” happen in terms of disease progression.
The concept of rigidity, in this context, refers to an in-
ability to maintain a dynamic view of one’s status, effect-
ively keeping evaluations static over time [37]. In other
words, rigid IE tend to be very emphatic and resistant
mental sets, which could be similar to certain core be-
liefs in the cognitive-behavioral approach [38]. It is ef-
fectively a form of mindlessness, in which an idea is
unchanged over time even with changes in situation or
context [39, 40]. Cognitive rigidity, which is the reverse
of cognitive flexibility, is generally considered a stable
characteristic over time [41]. Similar to flexibility, how-
ever, rigidity could change over time, for example as a
result of a psychological intervention [42].
Under the lens of the Illness Expectation model, the
placebo response is not necessarily the arising of new,
treatment-related expectations, but it could represent
the modification of a previously existing mindset. How-
ever, the IE effects are not limited to placebo responses.
Placebos are an external manipulation, often achieved
with some form of ambiguity or deception (e.g., a “fake”
pill), while IEs are self-created, although they can be in-
fluenced by external manipulations (e.g., doctor’s opin-
ions, information from other patients).
It is here suggested that IE could influence symptoms
and disease progressions (i.e., medical outcomes) with
two ways: a behavioral way and a non-behavioral way
(Fig. 1). The former refers to behavioral changes, includ-
ing adherence to the treatment and lifestyle (physical ac-
tivity, eating habits…) modifications. The non-behavioral
way refers to the physiological changes “directly” influ-
enced by the expectations, mirroring the placebo/nocebo
effect, but observed without a primer.
While expectations and rigidity focus emphasize the
cognitive level of the mind/body interaction, emotions
and stress can also interact with the process, with differ-
ent pathways. Emotions (e.g., fear) could influence both
implicit and explicit expectations. They could lead to be-
havioral changes, and direct effects of negative emotions
on the body (e.g., immune system) are documented [29].
A peculiarity of this model is the role of rigidity, which
could represent a clinical target for psychological inter-
ventions. There are several psychological approaches
that could improve flexibility and discourage rigid think-
ing. Future studies could explore how these interven-
tions could modify the IE effects on the body.
The IE model, at the present, is based on indirect evi-
dence from the scientific literature and organized
through this theory. Empirical studies are warranted to
test its validity and provide direct data-driven conclu-
sions. One of the first problems that should be addressed
by this field is the development of tools for the expect-
ation assessment. While there are existing instruments
that assess expectations, most of them focus on treat-
ment expectations. For example, The Credibility/Expect-
ancy Questionnaire [43] explores treatment credibility
and expectancy, while the Stanford Expectations of
Treatment Scale [44] considers both positive and nega-
tive expectations. Although very important, treatment
expectancies do not inglobe the illness expectations as a
whole. Furthermore, considering the potential role of
both implicit and explicit components, self-reported
measures may not be able to fully assess the construct.
The use of instruments to assess implicit components
should be considered. Studying the effects of IE manipu-
lations on the body may provide important confirms/dis-
confirms to the mind/body connection hypothesis, with
the potential to lead to several clinical implications. Per-
haps the most important and ambitious one would be a
better understanding of how we can use a mechanism
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similar to the placebo effect, without the ethical burden
of deception. The meaningful use of the placebo effect
without deception has been suggested as a highly rele-
vant research topic in psychology [3]. It could push to
the limits our current understanding of the mind/body
connection, with yet to be explored opportunities for
clinical interventions.
Abbreviations
CSM: Common Sense Model; IE: Illness Expectation
Acknowledgements
I sincerely thank friends and colleagues who helped me developing this
theoretical work: Cesare Cavalera, Eleonora Volpato, Beppe Riva, Enrico
Molinari, Gian Mauro Manzoni, Paolo Banfi, Francesca Graziano, Ellen Langer,
Deborah Phillips, Kathering Bercovitz, and Colin Bosma.
Authors’ contributions
FP is the sole author. The author read and approved the final manuscript.
Funding
This work has been partially supported by a grant from BIAL Foundation
(grant number 220/2018) and Fondazione Cariplo, Italian private foundation
(call “Ricerca sociale - 2017”, rif. 2017–0954). The funding bodies had no role
in the design of the study and collection, analysis, and interpretation of data
and in writing the manuscript.
Availability of data and materials
Not applicable.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
Dr. Pagnini is an editorial board member for BMC Psychology.
Received: 6 November 2018 Accepted: 23 October 2019
References
1. Phillips D, Pagnini F. Health and the psychology of possibility. In: Critical
Mindfulness edn: Springer. 2016:173–82.
2. Benedetti F. Placebo effects: from the neurobiological paradigm to
translational implications. Neuron. 2014;84(3):623–37.
3. Geers AL, Miller FG. Understanding and translating the knowledge about
placebo effects: the contribution of psychology. Current opinion in
psychiatry. 2014;27(5):326–31.
4. Charlesworth JE, Petkovic G, Kelley JM, Hunter M, Onakpoya I, Roberts N,
Miller FG, Howick J. Effects of placebos without deception compared with
no treatment: a systematic review and meta-analysis. Journal of Evidence-
Based Medicine. 2017;10(2):97–107.
5. Kaptchuk TJ, Friedlander E, Kelley JM, Sanchez MN, Kokkotou E, Singer JP,
Kowalczykowski M, Miller FG, Kirsch I, Lembo AJ. Placebos without
deception: a randomized controlled trial in irritable bowel syndrome. PLoS
One. 2010;5(12):e15591.
6. Kleine-Borgmann J, Bingel U: Nocebo effects: neurobiological mechanisms
and strategies for prevention and optimizing treatment. In: International
review of neurobiology. Volume 138, edn. Edited by Colloca L: Elsevier; 2018:
271–283.
7. Zion SR, Crum AJ: Mindsets matter: a new framework for harnessing the
placebo effect in modern medicine. In: International review of neurobiology.
Volume 138, edn.: Elsevier; 2018: 137–160.
8. Geers AL, Wellman JA, Fowler SL, Helfer SG, France CR. Dispositional
optimism predicts placebo analgesia. J Pain. 2010;11(11):1165–71.
Fig. 1 Illness Expectation model
Pagnini BMC Psychology            (2019) 7:70 Page 4 of 5
9. Hyland ME, Geraghty AW, Joy OE, Turner SI. Spirituality predicts outcome
independently of expectancy following flower essence self-treatment. J
Psychosom Res. 2006;60(1):53–8.
10. Meissner K: Believing in the effectiveness of treatment: from placebo to
credition and back. In: Processes of Believing: The Acquisition, Maintenance,
and Change in Creditions. edn. Edited by Angel HF, Oviedo L, Paloutzian RF,
Runehov A, Seitz RJ: Springer; 2017: 125–137.
11. Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. Biological, clinical, and ethical
advances of placebo effects. Lancet. 2010;375(9715):686–95.
12. Benedetti F, Carlino E, Piedimonte A. Increasing uncertainty in CNS clinical
trials: the role of placebo, nocebo, and Hawthorne effects. The Lancet
Neurology. 2016;15(7):736–47.
13. Crum AJ, Zuckerman B. Changing mindsets to enhance treatment
effectiveness. Jama. 2017;317(20):2063–4.
14. Blasini M, Corsi N, Klinger R, Colloca L: Nocebo and pain: An overview of the
psychoneurobiological mechanisms. Pain reports 2017, 2(2).
15. Crum AJ, Leibowitz KA, Verghese A. Making mindset matter. Bmj. 2017;356:
j674.
16. Park C, Pagnini F, Reece A, Phillips D, Langer E. Blood sugar level follows
perceived time rather than actual time in people with type 2 diabetes. Proc
Natl Acad Sci. 2016;201603444.
17. Dionigi RA. Stereotypes of aging: their effects on the health of older adults.
Journal of Geriatrics. 2015;2015.
18. Petrie K, Weinman J. Why illness perceptions matter. Clinical Medicine. 2006;
6(6):536–9.
19. Leventhal H, Meyer D, Nerenz D. The common sense representation of
illness danger. Contributions to medical psychology. 1980;2:7–30.
20. Laferton JA, Kube T, Salzmann S, Auer CJ, Shedden-Mora MC. Patients'
expectations regarding medical treatment: a critical review of concepts and
their assessment. Front Psychol. 2017;8:233.
21. Cameron LD, Leventhal H: The self-regulation of health and illness
behaviour: psychology press; 2003.
22. Broadbent E, Petrie K, Main J, Weinman J. The brief illness perception
questionnaire. J Psychosom Res. 2006;60(6):631–7.
23. Moss-Morris R, Weinman J, Petrie K, Horne R, Cameron L, Buick D. The
revised illness perception questionnaire (IPQ-R). Psychol Health. 2002;17(1):
1–16.
24. Hagger MS, Orbell S. A meta-analytic review of the common-sense model
of illness representations. Psychol Health. 2003;18(2):141–84.
25. Petrie K, Weinman J. Patients’ perceptions of their illness: the dynamo of
volition in health care. Curr Dir Psychol Sci. 2012;21(1):60–5.
26. Sarafino EP, Smith TW: Health psychology: biopsychosocial interactions:
John Wiley & Sons; 2014.
27. Upton D, Thirlaway K. Promoting healthy behaviour: a practical guide. New
York: Routledge; 2014.
28. Petrie K, Jago LA, Devcich DA. The role of illness perceptions in patients
with medical conditions. Current opinion in psychiatry. 2007;20(2):163–7.
29. Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R. Emotions, morbidity, and
mortality: new perspectives from psychoneuroimmunology. Annu Rev
Psychol. 2002;53(1):83–107.
30. Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease
progression and mortality in cancer patients. Cancer. 2009;115(22):5349–61.
31. Colloca L, Miller FG. How placebo responses are formed: a learning
perspective. Philosophical Transactions of the Royal Society B: Biological
Sciences. 2011;366(1572):1859–69.
32. Rief W, Petrie KJ. Can psychological expectation models be adapted for
placebo research? Front Psychol. 2016;7:1876.
33. Corsi N, Colloca L. Placebo and nocebo effects: the advantage of measuring
expectations and psychological factors. Front Psychol. 2017;8:308.
34. Petrie KJ, Rief W. Psychobiological mechanisms of placebo and nocebo
effects: pathways to improve treatments and reduce side effects. Annu Rev
Psychol. 2019;70:599–625.
35. Kirsch I. Response expectancy as a determinant of experience and behavior.
Am Psychol. 1985;40(11):1189.
36. Koenig HG. Religion, spirituality, and health: a review and update. Advances
in mind-body medicine. 2015;29(3):19–26.
37. Schultz PW, Searleman A: Rigidity of thought and behavior: 100 years of
research. Genetic, social, and general psychology monographs 2002, 128(2):165.
38. Dobson KS. The science of CBT: toward a metacognitive model of change?
Behav Ther. 2013;44(2):224–7.
39. Langer E: Mindfulness: Addison-Wesley/Addison Wesley Longman; 1989.
40. Pagnini F, Philips D. Being mindful about mindfulness. Lancet Psychiatry.
2015;2(4):288.
41. Armbruster DJ, Ueltzhöffer K, Basten U, Fiebach CJ. Prefrontal cortical
mechanisms underlying individual differences in cognitive flexibility and
stability. J Cogn Neurosci. 2012;24(12):2385–99.
42. Scott W, Hann KE, McCracken LM. A comprehensive examination of
changes in psychological flexibility following acceptance and commitment
therapy for chronic pain. J Contemp Psychother. 2016;46(3):139–48.
43. Devilly GJ, Borkovec TD. Psychometric properties of the credibility/
expectancy questionnaire. J Behav Ther Exp Psychiatry. 2000;31(2):73–86.
44. Younger J, Gandhi V, Hubbard E, Mackey S. Development of the Stanford
expectations of treatment scale (SETS): a tool for measuring patient
outcome expectancy in clinical trials. Clinical Trials. 2012;9(6):767–76.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Pagnini BMC Psychology            (2019) 7:70 Page 5 of 5
